Perspective Therapeutics (CATX) Accounts Payables (2011 - 2026)

Perspective Therapeutics (CATX) has 16 years of Accounts Payables data on file, last reported at $26.5 million in Q1 2026.

• For the quarter ending Q1 2026, Accounts Payables rose 203.24% year-over-year to $26.5 million; the trailing twelve-month figure through Mar 2026 stood at $26.5 million (up 203.24% YoY), and the FY2025 full-year result was $20.5 million, up 98.31% from the prior year.
• Accounts Payables climbed to $26.5 million in Q1 2026, from $20.5 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $26.5 million in Q1 2026 to a low of $769000.0 in Q1 2022.
• A 5-year average of $8.6 million and a median of $6.1 million in 2024 frame the typical range for Accounts Payables.
• Across the five-year window, Accounts Payables soared 464.08% in 2024 and plunged 39.72% in 2025, its largest moves.
• Tracing CATX's Accounts Payables over 5 years: stood at $1.5 million in 2022, then soared by 348.35% to $6.9 million in 2023, then surged by 49.7% to $10.3 million in 2024, then jumped by 98.31% to $20.5 million in 2025, then increased by 29.13% to $26.5 million in 2026.
• Business Quant data shows CATX's Accounts Payables at $26.5 million in Q1 2026, $20.5 million in Q4 2025, and $13.1 million in Q3 2025.